Abstract
Background/Aims: Patients with inflammatory bowel disease (IBD) are at increased risk of cytomegalovirus (CMV) infection, likely due to malnutrition and immunosuppressive therapies. Cytomegalovirus infection may contribute to worse disease outcomes, including higher colectomy rates. However, the prognostic value of serum cytomegalovirus deoxyribonucleic acid (CMV-DNA) levels and the clini cal significance of CMV colitis remain unclear. This study aimed to assess the impact of CMV infection on the clinical course of IBD.
Materials and Methods: Retrospective analysis was performed on 141 hospitalized IBD patients with detectable serum CMV-DNA (>42 copies/mL). Cytomegalovirus colitis was diagnosed by histopathology or immunohistochemistry. Clinical features were compared between CMV colitis and non-colitis groups. Receiver operating characteristic analysis assessed the optimal CMV-DNA cut-off, and logistic regression identified predictors of adverse outcomes (mortality or colectomy).
Results: Cytomegalovirus colitis was identified in 18.4% of patients. While there were no significant differences in age, treatment his tory, or colectomy rates between groups, patients with CMV colitis had significantly higher serum CMV-DNA levels (median: 837 vs. 267 copies/mL; P = .019), longer hospitalization durations (P = .001), and more frequent comorbidities (P = .019). The optimal CMV-DNA cut off was 468.5 copies/mL (area under the curve (AUC) 0.64; sensitivity 61.5%, specificity 61.7%). Adverse outcomes occurred in 24% of cases. Extensive colitis (odds ratio 2.92; P = .034) independently predicted poor outcomes; CMV-DNA levels did not.
Conclusion: Cytomegalovirus colitis is an uncommon but clinically significant complication in IBD flares. Although high serum CMV DNA levels were associated with CMV colitis, their diagnostic value was limited. Extensive colitis is an independent predictor of poor outcomes.
Cite this article as: Dursun B, Gumussoy M, T.rüner M. Clinical impact of cytomegalovirus infection in patients with inflammator bowel disease. Turk J Gastroenterol. 2026;37(3):373-379.
Most read articles by the same author(s)
- Murat Toruner, Metin Basaranoglu, Ozlen Atug, Omer Senturk, Filiz Akyuz, Cem Cekic, Hulya Over Hamzaoglu, Fatih Tekin, Orhan Sezgin, Hale Akpinar, Aykut Ferhat Celik, Ahmet Tezel, Huseyin Savas Gokturk, Taylan Kav, Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn’s Disease in Routine Clinical Practice in Turkey , Turkish Journal of Gastroenterology: Vol. 33 No. 5 (2022): Turkish Journal of Gastroenterology
- Orhan Sezgin, Hale Akpınar, Birol Özer, Murat Törüner, Kadir Bal, Serhat Bor, The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver , Turkish Journal of Gastroenterology: Vol. 34 No. 6 (2023): Turkish Journal of Gastroenterology
- Ayşegül SAPMAZ, Senem Ceren KARATAYLI, Ülkü DAĞLI, Zeki Mesut Yalın KILIÇ, Murat TÖRÜNER, Yasemin ÇELİK, Muhip ÖZKAN, İrfan SOYKAN, Hülya ÇETİNKAYA, Aysel ÜLKER, Ali ÖZDEN, A. Mithat BOZDAYI, Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease , Turkish Journal of Gastroenterology: Vol. 19 No. 3 (2008): Turkish Journal of Gastroenterology
- Orhan Sezgin, Hale Akpınar, Birol Özer, Murat Törüner, Kadir Bal, Serhat Bor, Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey , Turkish Journal of Gastroenterology: Vol. 30 No. 12 (2019): Turkish Journal of Gastroenterology
- Murat Törüner, Hale Akpınar, Filiz Akyüz, Ülkü Dağlı, Hülya Över Hamzaoğlu, Ahmet Tezel, Belkıs Ünsal, Süleyman Yıldırım, Aykut Ferhat Çelik, 2019 Expert opinion on biological treatment use in inflammatory bowel disease management , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 4 (2019): Turkish Journal of Gastroenterology
- Murat Törüner, Nalan Gülşen Ünal, Epigenetics of Inflammatory Bowel Diseases , Turkish Journal of Gastroenterology: Vol. 34 No. 5 (2023): Turkish Journal of Gastroenterology
- Murat Törüner, İsmail Hakkı Kalkan, Filiz Akyüz, Ahmet Tezel, Aykut Ferhat Çelik, Turkish IBD Organization’s Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic , Turkish Journal of Gastroenterology: Vol. 32 No. 6 (2021): Turkish Journal of Gastroenterology
- Murat TÖRÜNER, Özlem ERKAN, İrfan SOYKAN, A. Mithat BOZDAYI, Hülya ÇETİNKAYA, Cihan YURDAYDIN, Özden UZUNALİMOĞLU, Ali ÖZDEN, Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease , Turkish Journal of Gastroenterology: Vol. 15 No. 4 (2004): Turkish Journal of Gastroenterology
- Mübin Özercan, Zeynep Melekoğlu Ellik, Ayhan Parmaksız, Mesut Gümüşsoy, Serkan Duman, Necati Örmeci, Liver Stiffness and Steatosis Measurements with iLivTouch and FibroScan: A Comparative Study , Turkish Journal of Gastroenterology: Vol. 35 No. 8 (2024): Turkish Journal of Gastroenterology
- Gülseren Seven, Senem Ceren Karataylı, S.Kenan KÖSE, Mustafa YAKUT, Gökhan KABAÇAM, Murat TÖRÜNER, Aylin OKÇU HEPER, Michael VOELKER, Esra ERDEN, A. Mithat Bozdayı, Özden UZUNALİMOĞLU, Hakan BOZKAYA, Cihan Yurdaydın, Detlef SCHUPPAN, Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D , Turkish Journal of Gastroenterology: Vol. 22 No. 3 (2011): Turkish Journal of Gastroenterology

This work is licensed under a Creative Commons Attribution 4.0 International License.